Glaukos (GKOS) Cash from Investing Activities (QoQ) (2014 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Glaukos | 6.00 Bn | 5.90 Bn | 117.23 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 166.10% |
| Dec 31, 2025 | -297.95% |
| Sep 30, 2025 | 80.79% |
| Jun 30, 2025 | 43.75% |
| Mar 31, 2025 | -413.46% |
| Dec 31, 2024 | -61.43% |
| Sep 30, 2024 | -12.34% |
| Jun 30, 2024 | 218.65% |
| Mar 31, 2024 | -127.40% |
| Dec 31, 2023 | -186.74% |
| Sep 30, 2023 | -42.60% |
| Jun 30, 2023 | 287.62% |
| Mar 31, 2023 | -183.05% |
| Dec 31, 2022 | -31.72% |
| Sep 30, 2022 | 153.28% |
| Jun 30, 2022 | 263.30% |
| Mar 31, 2022 | 33.53% |
| Dec 31, 2021 | 65.96% |
| Sep 30, 2021 | -1,181.37% |
| Jun 30, 2021 | 90.43% |
| Mar 31, 2021 | -514.72% |
| Dec 31, 2020 | 98.09% |
| Sep 30, 2020 | -778.51% |
| Jun 30, 2020 | -3,390.92% |
| Mar 31, 2020 | -98.74% |
| Dec 31, 2019 | 1,322.68% |
| Sep 30, 2019 | -580.13% |
| Jun 30, 2019 | 65.03% |
| Mar 31, 2019 | 90.35% |
| Dec 31, 2018 | -199.26% |
| Sep 30, 2018 | -333.73% |
| Jun 30, 2018 | 148.31% |
| Mar 31, 2018 | 31.68% |
| Dec 31, 2017 | -432.92% |
| Sep 30, 2017 | -24.94% |
| Jun 30, 2017 | 45.05% |
| Mar 31, 2017 | 26.45% |
| Dec 31, 2016 | 71.89% |
| Sep 30, 2016 | -120.90% |
| Jun 30, 2016 | 45.76% |
| Mar 31, 2016 | 87.90% |
| Dec 31, 2015 | -38,220.22% |
| Sep 30, 2015 | -454.55% |
| Jun 30, 2015 | 84.65% |
| Mar 31, 2015 | 26.12% |
| Dec 31, 2014 | -1,978.57% |